Parco Pharmaceuticals Private Limited
About Parco Pharmaceuticals Private Limited
Data last updated:
Parco Pharmaceuticals Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the fabricated metal products segment of the plastics and polymers sector. It was incorporated on 01 August 1984 and has been in existence for over 42 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24239PN1984PTC033640. Its GSTIN is 27AABCP2570N2Z3 (Maharashtra). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹8.53 Lakh. It is led by directors including Vandana Vijaykumar Inamdar and Shardul Amit Inamdar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Pune, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.96 Lakh, a decline of 17% compared to the previous year. For the same year it recorded a net profit of ₹21,965 (net margin 4.4%) and EBITDA of ₹31,655 (EBITDA margin 6.4%). Revenue has grown at a compounded annual rate (CAGR) of 24% over three years and 17% over five years.
As per MCA filings, the company has satisfied charges of ₹13.65 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Parco Pharmaceuticals has one previous CIN (Corporate Identification Number): U24239MH1984PTC033640. The current CIN is U24239PN1984PTC033640, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239PN1984PTC033640 | Current |
| U24239MH1984PTC033640 | Previous |
Contact details
Parco Pharmaceuticals Private Limited's registered office is in Pune, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressFlat No.402 Lotus Residency Cts No.681, S.No.15/12 Plot No.5 Sangam Press Road Kothrud, Pune, Maharashtra, India – 411038
- IndustryPlastics, Fabricated Metal Products, Plastic Products, Non-Metallic Mineral Products, Rubber Products
To see the full contact details of Parco Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Parco Pharmaceuticals is manufacturing. In detail, this covers manufacture of chemicals and chemical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products |
To see the full business activity and turnover split of Parco Pharmaceuticals Private Limited, buy the company report.
Financials of Parco Pharmaceuticals Private Limited
FY 2025 filings availableParco Pharmaceuticals Private Limited reported revenue of ₹4.96 Lakh (down 17% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 17% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 17%. EBITDA rose 146% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹31,655 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹21,965 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.4% | ||||
| Net Profit Margin | 4.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Parco Pharmaceuticals Private Limited, buy the company report.
Board of directors of Parco Pharmaceuticals Private Limited
Parco Pharmaceuticals has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vandana Vijaykumar Inamdar | Director | 16 Jul 2024 | 2 Years 3 Months | Current |
| Shardul Amit Inamdar | Director | 24 Jul 2024 | 2 Years 3 Months | Current |
| Amit Vijaykumar Inamdar Also directs: Indologic Systems Private Limited | Additional Director | 30 Mar 2025 | 1 Years 7 Months | Current |
Auditor
Parco Pharmaceuticals Private Limited is audited by RAVEENDRAMANOHARKHADILKAR for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAVEENDRAMANOHARKHADILKAR | FY 2017 | 034990 |
Shareholding
The shareholding of Parco Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Parco Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Oct 1994 | 90090043 | The United Western Bank Ltd | ₹4.2 Lakh | Satisfied | |
| 12 Oct 1994 | 90090034 | The United Western Bank Ltd | ₹6.45 Lakh | Satisfied | |
| 24 Apr 1991 | 90083752 | The Sangli Bank Ltd. | ₹1.5 Lakh | Satisfied | |
| 23 Jul 1990 | 90087673 | The Sangli Bank Ltd. | ₹1.5 Lakh | Satisfied |
To see the full charge records of Parco Pharmaceuticals Private Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
No court or tribunal cases involving Parco Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Parco Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Parco Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCP2570N2Z3 | Maharashtra | Active | 13 Sep 2017 |
To see the full GST registrations and return filing status of Parco Pharmaceuticals Private Limited, buy the company report.
Recent activity
Parco Pharmaceuticals Private Limited has 9 board changes on record since 1984: 4 appointments and 5 cessations. The latest: Amit Vijaykumar Inamdar was appointed as Additional Director on 30 Mar 2025.
8 earlier events are in the company report.
Frequently asked questions
Parco Pharmaceuticals is an active private limited company based in Pune, Maharashtra, India. The company works in fabricated metal products, within the plastics industry. It was incorporated on 01 August 1984 (42+ years old) and is registered under CIN U24239PN1984PTC033640.
Parco Pharmaceuticals has 3 current directors:
- Vandana Vijaykumar Inamdar - Director
- Shardul Amit Inamdar - Director
- Amit Vijaykumar Inamdar - Additional Director
The latest financial statements of Parco Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Parco Pharmaceuticals is 27AABCP2570N2Z3, registered in Maharashtra. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Parco Pharmaceuticals is U24239PN1984PTC033640. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Parco Pharmaceuticals was incorporated on 01 August 1984, making it 42+ years old. It is registered with the Registrar of Companies, Pune.
Amit Vijaykumar Inamdar was appointed as Additional Director on 30 Mar 2025. Vijaykumar Eknath Inamdar ceased to be Director on 21 Nov 2024. Shardul Amit Inamdar ceased to be Additional Director on 29 Sep 2024. Parco Pharmaceuticals has 9 board changes on record in total.
The registered office of Parco Pharmaceuticals is at Flat No.402 Lotus Residency Cts No.681, S.No.1512 Plot No.5 Sangam Press Road Kothrud, Pune, Maharashtra, India – 411038.
Parco Pharmaceuticals operates in the plastics industry, in the fabricated metal products segment.
Parco Pharmaceuticals has no open charges and satisfied charges of ₹13.65 Lakh as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
